Haemonetics Corporation · NYSE:HAE
North Peak Capital Management, LLC reported a 5.10% stake in Haemonetics Corporation (Schedule 13G)
Event Feb 24, 2026 · Filed Mar 3, 2026
North Peak Capital Management, LLC reported a 5.10% stake in Haemonetics Corporation, 2,370,495 shares, as a passive investor on Feb 24, 2026. Filed Mar 3, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 2,370,495
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| North Peak Capital Management, LLC | 5.10% | 2,370,495 |
| North Peak Capital GP, LLC | 4.00% | 1,882,037 |
| North Peak Capital Partners, LP | 0.30% | 135,354 |
| North Peak Capital Partners II, LP | 2.10% | 993,566 |
| North Peak Capital Alpha Fund, LP | 1.40% | 651,061 |
| North Peak Capital Ultra Fund, LP | 0.20% | 102,056 |
| Michael Kevin Kahan | 4.00% | 1,882,037 |
| Jeremy Steven Kahan | 4.00% | 1,882,037 |
Source
Related
- Haemonetics Corporation
- North Peak Capital Management, LLC
- Haemonetics Corporation shareholders
- Schedule 13G/A · North Peak Capital Management, LLC · May 13, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 12, 2026
- Form 4 · Abernathy Robert E · Jul 28, 2026
- Form 4 · Madaus Martin D · Jul 28, 2026
- Form 4 · Zane Ellen M · Jul 28, 2026
- Form 4 · Pomeroy Claire · Jul 28, 2026